Michael J. Mitchell
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Immunology top 0.5%
- Immunotherapy and Immune Responses
Papers in
-
- RNA Interference and Gene Delivery 73
- Advanced biosensing and bioanalysis techniques 34
- Lipid Membrane Structure and Behavior 12
- Oncology 33
- CAR-T cell therapy research 18
- Cancer Cells and Metastasis 9
- Co-authors
- Róbert Langer (12 shared papers)Margaret M. Billingsley (33 shared papers)Rebecca M. Haley (15 shared papers)Marissa E. Wechsler (1 shared paper)Nicholas A. Peppas (1 shared paper)Carl H. June (8 shared papers)Rachel Riley (8 shared papers)Michael R. King (14 shared papers)
- Journals
- Nano Letters (11 papers)Journal of Controlled Release (8 papers)Nature Communications (7 papers)ACS Nano (6 papers)Proceedings of the National Academy of Sciences (6 papers)
- Partner nations
- United StatesChinaBrazil
In The Last Decade
Michael J. Mitchell
163 papers receiving 18.3k citations
Michael J. Mitchell's Hit Papers
Peers
Comparison fields: 5 of 182
- Biomaterials 4.0k
- Immunology 3.4k
- Pharmaceutical Science 886
- Biomedical Engineering 5.7k
- Molecular Biology 8.6k
Countries citing papers authored by Michael J. Mitchell
This map shows the geographic impact of Michael J. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Mitchell more than expected).
Fields of papers citing papers by Michael J. Mitchell
This network shows the impact of papers produced by Michael J. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Mitchell. The network helps show where Michael J. Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engineering precision nanoparticles for drug delivery Hit paper breakdown → | 2020 | 5790 |
| 2 | Delivery technologies for cancer immunotherapy Hit paper breakdown → | 2019 | 2096 |
| 3 | Advances in Biomaterials for Drug Delivery Hit paper breakdown → | 2018 | 728 |
| 4 | Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy Hit paper breakdown → | 2016 | 608 |
| 5 | Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering Hit paper breakdown → | 2020 | 495 |
| 6 | An ionizable lipid toolbox for RNA delivery Hit paper breakdown → | 2021 | 452 |
| 7 | Microfluidic formulation of nanoparticles for biomedical applications Hit paper breakdown → | 2021 | 313 |
| 8 | 2020 | 263 | |
| 9 | Nanomaterials for T-cell cancer immunotherapy Hit paper breakdown → | 2021 | 261 |
| 10 | Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device Hit paper breakdown → | 2021 | 248 |
| 11 | 2017 | 218 | |
| 12 | 2020 | 197 | |
| 13 | 2014 | 184 | |
| 14 | 2013 | 182 | |
| 15 | 2019 | 174 | |
| 16 | Ionizable lipid nanoparticles for in utero mRNA delivery Hit paper breakdown → | 2021 | 169 |
| 17 | Nanoparticle protein corona: from structure and function to therapeutic targeting Hit paper breakdown → | 2023 | 167 |
| 18 | Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines Hit paper breakdown → | 2023 | 166 |
| 19 | 2013 | 163 | |
| 20 | 2019 | 162 |
About Michael J. Mitchell
Michael J. Mitchell is a scholar working on Molecular Biology, Oncology, Immunology, Biomedical Engineering and Biomaterials, having authored 166 papers that have together received 18.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (73 papers), Advanced biosensing and bioanalysis techniques (34 papers), Nanoparticle-Based Drug Delivery (18 papers), CAR-T cell therapy research (18 papers), Immunotherapy and Immune Responses (16 papers), Virus-based gene therapy research (14 papers), Lipid Membrane Structure and Behavior (12 papers) and Cancer Cells and Metastasis (9 papers). The work is most often cited by research in Biomaterials (4.0k citations), Immunology (3.4k citations), Pharmaceutical Science (886 citations), Biomedical Engineering (5.7k citations) and Molecular Biology (8.6k citations). Michael J. Mitchell has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include Róbert Langer, Margaret M. Billingsley, Rebecca M. Haley, Marissa E. Wechsler, Nicholas A. Peppas, Carl H. June, Rachel Riley, Michael R. King, Xuexiang Han and Drew Weissman. Their work appears in journals such as Nano Letters, Journal of Controlled Release, Nature Communications, ACS Nano and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.